Royal Bank Of Canada Soleno Therapeutics Inc Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.22 - $0.47 $31 - $68	-145 Reduced 51.42%	137 $0
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $2,880 - $4,033	-3,601 Reduced 92.74%	282 $0
Q2 2021 Aug 16, 2021	BUY	$0.97 - $1.32 $3,766 - $5,125	3,883 New	3,883 $4,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.